[Soft tissue tumors: indications and results of hyperthermia].
Issels
R D
RD
Institut für klinische Hämatologie (GSF), Grosshadern.
Bosse
D
D
Starck
M
M
Abdel-Rahman
S
S
Jauch
K W
KW
Schildberg
F W
FW
Wilmanns
W
W
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced; D007069:Ifosfamide / Q000008:administration & dosage; D008297:Male; D015080:Mesna / Q000008:administration & dosage; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D012983:Soft Tissue Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D015996:Survival Rate
D005047:Etoposide; D004317:Doxorubicin; D015080:Mesna; D007069:Ifosfamide
Weichteiltumoren: Indikation und Ergebnisse der Hyperthermie.